The signalling axis of chemokine (C-C motif) ligand 2 (CCL2)–C-C chemokine receptor type 2 (CCR2) suppresses tumour metastasis through reduced angiogenesis in preclinical models. The gene discussed is CCR2; the disease is neoplasm.